Obinutuzumab induces depletion of NK cells in patients with chronic lymphocytic leukemia.
García-Muñoz R, Aguinaga L, Feliu J, Anton-Remirez J, Jorge-Del-Val L, Casajús-Navasal A, Nebot-Villacampa MJ, Daroca-Fernandez I, Domínguez-Garrido E, Rabasa P, Panizo C.
García-Muñoz R, et al.
Immunotherapy. 2018 Mar 1;10(6):491-499. doi: 10.2217/imt-2017-0147.
Immunotherapy. 2018.
PMID: 29562857